Brazil
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.93 B
|
Dec. 31, 2023 | USD 4.80 | 0.53% |
|
Brazil |
|
2 |
USD 1.16 B
|
Dec. 31, 2023 | USD 0.31 | -1.64% |
|
Brazil |
|
3 |
USD 346.94 M
|
Dec. 31, 2023 | USD 2.04 | 0.87% |
|
Brazil |
|
4 |
USD 217.75 M
|
Dec. 31, 2023 | USD 16.15 | -4.10% |
|
Brazil |
|
5 |
USD 151.15 M
|
Dec. 31, 2023 | USD 1.95 | -3.23% |
|
Brazil |
|
6 |
USD 69.10 M
|
Dec. 31, 2023 | USD 2.21 | -0.40% |
|
Brazil |
|
7 |
USD 17.31 M
|
Dec. 31, 2023 | USD 1.66 | 0.01% |
|
Brazil |
|
8 |
USD 12.89 M
|
Dec. 31, 2023 | USD 1.97 | 2.04% |
|
Brazil |
The Biotechnology company in Brazil with the highest Current Liabilities is Rede D'Or São Luiz S.A. (São Paulo Stock Exchange: RDOR3.SA) at USD 2.93 B.
The Biotechnology company in Brazil with the lowest Current Liabilities is Baumer S.A. (São Paulo Stock Exchange: BALM4.SA) at USD 12.89 M.
The top 10 Biotechnology companies in Brazil by Current Liabilities are Rede D'Or São Luiz S.A., Diagnósticos da América S.A., Fleury S.A., Afya Limited, Centro de Imagem Diagnósticos S.A., Blau Farmacêutica S.A., Biomm S.A. and Baumer S.A..
The bottom 10 Biotechnology companies in Brazil by Current Liabilities are Baumer S.A., Biomm S.A., Blau Farmacêutica S.A., Centro de Imagem Diagnósticos S.A., Afya Limited, Fleury S.A., Diagnósticos da América S.A. and Rede D'Or São Luiz S.A..